Department of Pathology,
Institute of Cell Engineering,
Department of Pathology, Institute of Cell Engineering
Mathias Oelke has not added Biography.
If you are Mathias Oelke and would like to personalize this page please email our Author Liaison for assistance.
Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells.
Nature medicine May, 2003 | Pubmed ID: 12704385
Identification of beta-subunit of bacterial RNA-polymerase--a non-species-specific bacterial protein--as target of antibodies in primary biliary cirrhosis.
Digestive diseases and sciences Mar, 2003 | Pubmed ID: 12757171
HLA-Ig-based artificial antigen-presenting cells: setting the terms of engagement.
Clinical immunology (Orlando, Fla.) Mar, 2004 | Pubmed ID: 15047202
Quality and quantity: new strategies to improve immunotherapy of cancer.
Trends in molecular medicine May, 2004 | Pubmed ID: 15121045
Intracranial aspergillosis in a non-immunocompromised patient treated for muscle-invasive bladder cancer.
International journal of urology : official journal of the Japanese Urological Association Aug, 2004 | Pubmed ID: 15285760
Technological advances in adoptive immunotherapy.
Drugs of today (Barcelona, Spain : 1998) Jan, 2005 | Pubmed ID: 15753966
Artificial antigen-presenting cells: artificial solutions for real diseases.
Trends in molecular medicine Sep, 2005 | Pubmed ID: 16103011
Evaluation of topoisomerase-1-specific CD8+ T-cell response in systemic sclerosis.
Annals of the New York Academy of Sciences Dec, 2005 | Pubmed ID: 16461796
Differential innate immune cell activation and proinflammatory response in Anaplasma phagocytophilum infection.
Infection and immunity Jun, 2007 | Pubmed ID: 17403880
Expansion of human cytomegalovirus-specific T lymphocytes from unfractionated peripheral blood mononuclear cells with artificial antigen-presenting cells.
Transfusion Nov, 2007 | Pubmed ID: 17958544
Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.
Blood Apr, 2008 | Pubmed ID: 18096763
In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC).
Cancer immunology, immunotherapy : CII Feb, 2009 | Pubmed ID: 18563409
Ascites specific inhibition of CD1d-mediated activation of natural killer T cells.
Clinical cancer research : an official journal of the American Association for Cancer Research Dec, 2008 | Pubmed ID: 19047090
Ex vivo induction and expansion of natural killer T cells by CD1d1-Ig coated artificial antigen presenting cells.
Journal of immunological methods Jul, 2009 | Pubmed ID: 19446558
Development of an artificial-antigen-presenting-cell-based assay for the detection of low-frequency virus-specific CD8(+) T cells in whole blood, with application for measles virus.
Clinical and vaccine immunology : CVI Jul, 2009 | Pubmed ID: 19494085
Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity.
Anticancer research Aug, 2009 | Pubmed ID: 19661290
In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer.
Cancer research Dec, 2009 | Pubmed ID: 19934317
Soluble recombinant CMVpp65 spanning multiple HLA alleles for reconstitution of antiviral CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation.
Journal of immunotherapy (Hagerstown, Md. : 1997) Jan, 2010 | Pubmed ID: 19952955
Overview of a HLA-Ig based "Lego-like system" for T cell monitoring, modulation and expansion.
Immunologic research Jul, 2010 | Pubmed ID: 20087680
Dynamic regulation of functionally distinct virus-specific T cells.
Proceedings of the National Academy of Sciences of the United States of America Feb, 2010 | Pubmed ID: 20133680
Dietary fatty acids modulate antigen presentation to hepatic NKT cells in nonalcoholic fatty liver disease.
Journal of lipid research Jul, 2010 | Pubmed ID: 20185414
Killer artificial antigen-presenting cells: the synthetic embodiment of a 'guided missile'.
Immunotherapy Jul, 2010 | Pubmed ID: 20636007
Immunotherapy with enhanced self immune cells.
Discovery medicine Jun, 2004 | Pubmed ID: 20704987
Decline of influenza-specific CD8+ T cell repertoire in healthy geriatric donors.
Immunity & ageing : I & A , 2011 | Pubmed ID: 21846352
Heat shock protein 70/peptide complexes: potent mediators for the generation of antiviral T cells particularly with regard to low precursor frequencies.
Journal of translational medicine , 2011 | Pubmed ID: 21992180
IL-2 Upregulates CD86 Expression on Human CD4+ and CD8+ T Cells.
Journal of immunology (Baltimore, Md. : 1950) Feb, 2012 | Pubmed ID: 22246628
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados